Carotenoids and markers of oxidative stress in human observational studies and intervention trials: Implications for chronic diseases

Antioxidants

Volumn 8, Issue 6, 2019, Pages

  Bohn, Torsten ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Beta carotene; Biomarkers; Cardio metabolic diseases; Carotenes; Cytokines; Humans; Lycopene; Metabolites; Nuclear factors; Tissue concentrations; Transcription factors; Xanthophylls

Indexed keywords

EID: 85069688093     PISSN: None     EISSN: 20763921     Source Type: Journal    
DOI: 10.3390/antiox8060179     Document Type: Review

References (218)

1. Steiger, S.; Perez-Fons, L.; Fraser, P.D.; Sandmann, G. Biosynthesis of a novel C30 carotenoid in bacillus firmus isolates. J. Appl. MicroBiol. 2012, 113, 888–895.
2. Yabuzaki, J. Carotenoids database: Structures, chemical fingerprints and distribution among organisms. Database 2017, 2017, doi:10.1093/database/bax004.
3. Kim, S.H.; Kim, M.S.; Lee, B.Y.; Lee, P.C. Generation of structurally novel short carotenoids and study of their biological activity. Sci. Rep. 2016, 6, 21987.
4. Squillaci, G.; Parrella, R.; Carbone, V.; Minasi, P.; La Cara, F.; Morana, A. Carotenoids from the extreme halophilic archaeon Haloterrigena turkmenica: Identification and antioxidant activity. Extremophiles 2017, 21, 933–945.
5. Chen, C.W.; Hsu, S.H.; Lin, M.T.; Hsu, Y.H. Mass production of C50 carotenoids by haloferax mediterranei in using extruded rice bran and starch under optimal conductivity of brined medium. BioProc.ess Biosyst. Eng. 2015, 38, 2361–2367.
6. Heider, S.A.; Peters-Wendisch, P.; Wendisch, V.F.; et al. Metabolic engineering for the microbial production of carotenoids and related products with a focus on the rare C50 carotenoids. Appl. MicroBiol. Biotechnol. 2014, 98, 4355–4368.
7. Hou, J.; Cui, H.L. In vitro antioxidant, antihemolytic, and anticancer activity of the carotenoids from halophilic archaea. Curr. MicroBiol. 2018, 75, 266–271.
8. Böhm, V.; Borel, P.; Corte-Real, J. From carotenoid intake to carotenoid/metabolite blood and tissue concentrations—Implications for dietary intake recommendations. Nutr. Rev. 2018, under review.
9. Manach, C.; Scalbert, A.; Morand C; Rémésy, R.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747.
10. Kancheva, V.D.; Kasaikina, O.T. Bio-antioxidants—A chemical base of their antioxidant activity and beneficial effect on human health. Curr. Med. Chem. 2013, 20, 4784–4805.
11. Erdman, J.W.; Jr., Ford, N.A.; Lindshield, B.L. Are the health attributes of lycopene related to its antioxidant function? Arch. BioChem. Biophys. 2009, 483, 229–235.
12. Briviba, K.; Schnabele, K.; Rechkemmer, G.; Bub, A. Supplementation of a diet low in carotenoids with tomato or carrot juice does not affect lipid peroxidation in plasma and feces of healthy men. J. Nutr. 2004, 134, 1081–1083.
13. Rühl, R. Effects of dietary retinoids and carotenoids on immune development. Proc. Nutr. Soc. 2007, 66, 458–469.
14. Bonet, M.L.; Canas, J.A.; Ribot, J.; Palou, A. Carotenoids in adipose tissue biology and obesity. Subcell. BioChem. 2016, 79, 377–414.
15. FAO. Enrichment of dried skim milk with special reference to vitamin A. Food Nutr. 1977, 3, 2–7.
16. Linnewiel, K.; Ernst, H.; Caris-Veyrat, C.; Ben-Dor, A.; Kampf, A.; Salman, H.; Danilenko, M.; Levy, J.; Sharoni, Y. Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic. Biol. Med. 2009, 47, 659–667.
17. Linnewiel-Hermoni, K.; Motro, Y.; Miller, Y.; Levy, J.; Sharoni, Y. Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups. Free Radic. Biol. Med. 2014, 75, 105–120.
18. Kaulmann, A.; Bohn T. Carotenoids, inflammation, and oxidative stress—Implications of cellular signaling pathways and relation to chronic disease prevention. Nutr. Res. 2014, 34, 907–929.
19. Buijsse, B.; Feskens, E.J.; Schlettwein-Gsell, D.; Ferry, M.; Kok, F.J.; Kromhout, D.; de Groot, L.C. Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: The survey in Europe on nutrition and the elderly, a concerted action (SENECA). Am. J. Clin. Nutr. 2005, 82, 879–886.
20. Beydoun, M.A.; Chen, X.; Jha, K.; Beydoun, H.A.; Zonderman, A.B.; Canas, J.A. Carotenoids, vitamin A, and their association with the metabolic syndrome: A systematic review and meta-analysis. Nutr. Rev. 2019, 77, 32–45.
21. Donaldson, M.S. A carotenoid health index based on plasma carotenoids and health outcomes. Nutrients 2011, 3, 1003–1022.
22. CDC. National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population 1999–2002; CDC: Atlanta, GA, USA, 2008.
23. Albanes, D.; Heinonen, O.P.; Taylor, P.R.; Virtamo, J.; Edwards, B.K.; Rautalahti, M.; Hartman, A.M.; Palmgren, J.; Freedman, L.S.; Haapakoski, J.; et al. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 1996, 88, 1560–1570.
24. Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L., Jr.; Valanis, B.; Williams, J.H., Jr.; et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996, 334, 1150–1155.
25. Cullen, M.R.; Barnett, M.J.; Balmes, J.R.; Cartmel, B.; Redlich, C.A.; Brodkin, C.A.; Barnhart, S.; Rosenstock, L.; Goodman, G.E.; Hammar, S.P.; et al. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial. Am. J. Epidemiol. 2005, 161, 260–270.
26. Albanes, D.; Virtamo, J.; Taylor, P.R.; Rautalahti, M.; Pietinen, P.; Heinonen, O.P. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the alpha-tocopherol, beta-carotene cancer prevention study. Am. J. Clin. Nutr. 1997, 66, 366–372.
27. Bohn, T. Carotenoids, chronic disease prevention and dietary recommendations. Int. J. Vitam. Nutr. Res. 2018, 1, 10.
28. Forrester, S.J.; Kikuchi, D.S.; Hernandes, M.S.; Xu, Q.; Griendling, K.K. Reactive oxygen species in metabolic and inflammatory signaling. Circ. Res. 2018, 122, 877–902.
29. USDA (2015) National Nutrient Database for Standard Reference Release 28. Available online: http://ndb.nal.usda.gov/ndb/foods/show (accessed on 5 November 2015).
30. Paetau, I.; Khachik, F.; Brown, E.D.; Beecher, G.R.; Kramer, T.R.; Chittams, J.; Clevidence, B.A. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am. J. Clin. Nutr. 1998, 68, 1187– 1195.
31. Biehler, E.; Alkerwi, A.; Hoffmann, L.; Krause, E.; Guillaume, M.; Lair, M.L.; Bohn,T. Contribution of violaxanthin, neoxanthin, phytoene and phytofluene to total carotenoid intake: Assessment in luxembourg. J. Food Compos. Anal. 2012, 25, 56–65.
32. Zhou, C.H.; Xu, C.J.; Sun, C.D.; Li, X.; Chen, K.S. Carotenoids in white-and red-fleshed loquat fruits. J. Agric. Food Chem. 2007, 55, 7822–7830.
33. Ambati, R.R.; Phang, S.M.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications—A review. Mar. Drugs 2014 12, 128-152.
34. Imai, A.; Oda, Y.; Ito, N.; Seki, S.; Nakagawa, K.; Miyazawa, T.; Ueda, F. Effects of dietary supplementation of astaxanthin and sesamin on daily fatigue: A randomized, double-blind, placebo-controlled, two-way crossover study. Nutrients 2018, 10, 281.
35. Timmermans B. Fucoxanthin: A Promising Bioproduct to Be Derived from Algae? Rijksuniversiteit: Groningen, The Netherlands, 2016.
36. Brizio, P.; Benedetto, A.; Righetti. M.; Prearo, M.; Gasco, L.; Squadrone, S.; Abete, M.C. Astaxanthin and canthaxanthin (xanthophyll) as supplements in rainbow trout diet: In vivo assessment of residual levels and contributions to human health. J. Agric. Food Chem. 2013, 61, 10954–10959.
37. Esatbeyoglu, T.; Rimbach, G. Canthaxanthin: From molecule to function. Mol. Nutr. Food Res. 2017, 61, 1600469.
38. EFSA. Scientific opinion on the re-evaluation of canthaxanthin (E 161 g) as a food additive. EFSA J. 2010, 8, 1852.
39. Sy, C.; Gleize, B.; Dangles, O.; Landrier, J.F.; Veyrat, C.C.; Borel, P. Effects of physicochemical properties of carotenoids on their bioaccessibility, intestinal cell uptake, and blood and tissue concentrations. Mol. Nutr. Food Res. 2012, 56, 1385–1397.
40. Burton, G.W.; Ingold, K.U. Beta-Carotene: An unusual type of lipid antioxidant. Science 1984, 224, 569–573.
41. Gruszecki, W.I.; Strzalka, K. Carotenoids as modulators of lipid membrane physical properties. Biochim. Biophys. Acta 2005, 1740, 108–115.
42. Krinsky, N.I.; Johnson, E.J. Carotenoid actions and their relation to health and disease. Mol. Asp. Med. 2005, 26, 459–516.
43. El-Agamey, A.; Lowe, G.M.; McGarvey, D.J.; Mortensen, A.; Phillip, D.M.; Truscott, T.G.; Young, A.J. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. BioChem. Biophys. 2004, 430, 37–48.
44. Schaich, K.M.; Borg, D.C. Fenton reactions in lipid phases. Lipids 1988, 23, 570–579.
45. Conn, P.F.; Lambert, C.; Land, E.J.; Schalch, W.; Truscott, T.G. Carotene-oxygen radical interactions. Free Radic. Res. Commun. 1992, 16, 401–408.
46. Chiste, R.C.; Freitas, M.; Mercadante, A.Z.; Fernandes, E. Carotenoids inhibit lipid peroxidation and hemoglobin oxidation, but not the depletion of glutathione induced by ROS in human erythrocytes. Life Sci. 2014, 99, 52–60.
47. Ito, F.; Sono, Y.; Ito, T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: Oxidative stress in diabetes, atherosclerosis, and chronic inflammation. AntiOxid.ants 2019, 8, 72.
48. Ayala, A.; Munoz, M.F.; Arguelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell Longev. 2014, 2014, 360438.
49. Sharma, R.A.; Gescher, A.; Plastaras, J.P.; Leuratti, C.; Singh, R.; Gallacher-Horley, B.; Offord, E.; Marnett, L.J.; Steward, W.P.; Plummer, S.M. Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 2001, 22, 1557–1560.
50. Nam, T.G. Lipid peroxidation and its toxicological implications. Toxicol. Res. 2011, 27, 1–6.
51. Spies-Martin, D.; Sommerburg, O.; Langhans, C.D.; Leichsenring, M. Measurement of 4-hydroxynonenal in small volume blood plasma samples: Modification of a gas chromatographic-mass spectrometric method for clinical settings. J. Chromatogr. B 2002, 774, 231–239.
52. Il’yasova, D.; Scarbrough, P.; Spasojevic, I. Urinary biomarkers of oxidative status. Clin. Chim. Acta 2012, 413, 1446–1453.
53. Kumar, A.; Dhillon, B.S.; Rao, D.N.; Menon, G.; Shankar, H.; Dhaliwal, L.K.; Leema, M.; Chandhiok, N.; Kumar, N.; Sehgal, R.; et al. Temporal trends of malondialdehyde in stored human plasma. Indian J. Clin. Biochem. 2012, 27, 405–409.
54. Tsikas, D.; Suchy, M.T.; Niemann, J.; Tossios, P.; Schneider, Y.; Rothmann, S.; Gutzki, F.M.; Frölich, J.C.; Stichtenoth, D.O.; et al. Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2alpha. FEBS Lett. 2012, 586, 3723–3730.
55. Da Silva, M.S.; Bilodeau, J.F.; Julien, P.; Rudkowska, I. Dietary fats and F2-isoprostanes: A review of the clinical evidence. Crit. Rev. Food Sci. Nutr. 2017, 57, 3929–3941.
56. Kaviarasan, S.; Muniandy, S.; Qvist, R.; Ismail, I.S. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: A review. J. Clin. Biochem. Nutr. 2009, 45, 1–8.
57. Kitano, S.; Hisatomi, H.; Hibi, N.; Kawano, K.; Harada, S. Improved method of plasma 8-Isoprostane measurement and association analyses with habitual drinking and smoking. World J. Gastroenterol. 2006, 12, 5846–5852.
58. Chen, Y.; Junger, W.G. Measurement of oxidative burst in neutrophils. Methods Mol. Biol. 2012, 844, 115– 124.
59. Slauch, J.M. How does the oxidative burst of macrophages kill bacteria? Still an open question. Mol. MicroBiol. 2011, 80, 580–583.
60. Min, D.B.; Boff, J.M. Chemistry and reaction of singlet oxygen in foods. Compr. Rev. Food Sci. Food Saf. 2002, 1, 58–72.
61. Ojima, F.; Sakamoto, H.; Ishiguro, Y.; Terao, J. Consumption of carotenoids in photosensitized oxidation of human plasma and plasma low-density lipoprotein. Free Radic. Biol. Med. 1993, 15, 377–384.
62. Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552, 335–344.
63. Valavanidis, A.; Vlachogianni, T.; Fiotakis, C. 8-hydroxy-2’-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health Part C 2009, 27, 120–139.
64. Cadet, J.; Douki, T.; Gasparutto, D.; Ravanat, J.L. Oxidative damage to DNA: Formation, measurement and biochemical features. Mutat. Res. 2003, 531, 5–23.
65. Poulsen, H.E.; Loft, S.; Prieme, H.; Vistisen, K.; Lykkesfeldt, J.; Nyyssonen, K.; Salonen, J.T. Oxidative DNA damage in vivo: Relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Radic. Res. 1998, 29, 565–571.
66. Goulinet, S.; Chapman, M.J. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids: Relevance to oxidative resistance and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 786–796.
67. Romanchik, J.E.; Morel, D.W.; Harrison, E.H. Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. J. Nutr. 1995, 125, 2610–2617.
68. Gao, S.; Liu, J. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chr. Dis. Transl. Med. 2017, 3, 89–94.
69. Itabe, H. Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: From atherosclerosis to periodontitis. J. Clin. Biochem. Nutr. 2012, 51, 1–8.
70. Itabe, H.; Ueda, M. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J. ATher.oscler. Thromb. 2007 14, 1-11.
71. Yin, H.; Xu, L.; Porter, N.A. Free radical lipid peroxidation: Mechanisms and analysis. Chem. Rev. 2011, 111, 5944–5972.
72. EFSA. Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health. EFSA J. 2018, 16, 5136.
73. Yamamoto, Y.; Kambayashi, Y.; Ueda, T. Assay of phospholipid hydroperoxides by chemiluminescence-based high-performance liquid chromatography. Methods Mol. Biol. 1998, 108, 63–70.
74. Granato, D.; Shahidi, F.; Wrolstad, R.; Kilmartin, P.; Melton, L.D.; Hidalgo, F.J.; Miyashita, K.; Camp, J.V.; Alasalvar, C.; Ismail, A.B. Antioxidant activity, total phenolics and flavonoids contents: Should we ban in vitro screening methods? Food Chem. 2018, 264, 471–475.
75. Alam, M.N.; Bristi, N.J.; Rafiquzzaman, M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm. J. 2013, 21, 143–152.
76. Garrett, A.R.; Murray, B.K.; Robison, R.A.; O’Neill, K.L. Measuring antioxidant capacity using the ORAC and TOSC assays. Methods Mol. Biol. 2010, 594, 251–262.
77. Gülçin, İ. (2015) Fe3+–Fe2+ transformation method: An important antioxidant assay. In Advanced Protocols in Oxidative Stress III; Armstrong, D., Eds.; Springer: New York, NY, USA, 2015; pp. 233–246.
78. Olszowy, M.; Dawidowicz, A.L. Is it possible to use the DPPH and ABTS methods for reliable estimation of antioxidant power of colored compounds? Chem. Pap. 2018, 72, 393–400.
79. Kedare, S.B.; Singh, R.P. Genesis and development of DPPH method of antioxidant assay. J. Food Sci. Technol. 2011, 48, 412–422.
80. Prior, R.L.; Hoang, H.; Gu, L.; Wu, X.; Bacchiocca, M.; Howard, L.; Hampsch-Woodill, M.; Huang, D.; Ou, B.; Jacob, R. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J. Agric. Food Chem. 2003, 51, 3273–3279.
81. Cano, A.; Alcaraz, O.; Acosta, M.; Arnao, M.B. On-line antioxidant activity determination: Comparison of hydrophilic and lipophilic antioxidant activity using the ABTS*+ assay. Redox. Rep. 2002, 7, 103–109.
82. Abramovic, H.; Grobin, B.; Poklar Ulrih, N.; Cigić, B. Relevance and standardization of in vitro antioxidant assays: ABTS, DPPH, and Folin-Ciocalteu. J. Chem. 2018, 2018, 9.
83. Huang, Y.; Li, W.; Su, Z.Y.; Kong, A.N. The complexity of the Nrf2 pathway: Beyond the antioxidant response. J. Nutr. Biochem. 2015, 26, 1401–1413.
84. Liu, T.; Zhang, L.; Joo, D.; Sun, S.C. NF-kappaB signaling in inflammation. Signal Transduct. Targ. Ther. 2017, 2, 17023.
85. Margaritelis, N.V.; Veskoukis, A.S.; Paschalis, V.; Vrabas, I.S.; Dipla, K.; Zafeiridis, A.; Kyparos, A.; Nikolaidis, M.G. Blood reflects tissue oxidative stress: A systematic review. Biomarkers 2015, 20, 97–108.
86. Fukai, T.; Ushio-Fukai, M. Superoxide dismutases: Role in redox signaling, vascular function, and diseases. AntiOxid. Redox. Signal 2011, 15, 1583–1606.
87. McCord, J.M. Superoxide dismutase, lipid peroxidation, and bell-shaped dose response curves. Dose Response 2008, 6, 223–238.
88. Sever, R.; Glass, C.K. Signaling by nuclear receptors. Cold Spring Harb. Perspect. Biol. 2013, 5, a016709.
89. Bohn, T.; Desmarchelier, C.; El, S.N.; Keijer, J.; van Schothorst, E.; Rühl, R.; Borel, P. beta-Carotene in the human body: Metabolic bioactivation pathways-from digestion to tissue distribution and excretion. Proc. Nutr. Soc. 2019, 78, 68–87.
90. Bonet, M.L.; Canas, J.A.; Ribot, J.; Palou, A. Carotenoids and their conversion products in the control of adipocyte function, adiposity and obesity. Arch. Biochem. Biophys. 2015, 572, 112–125.
91. le Maire, A.; Alvarez, S.; Shankaranarayanan, P.; Lera, A.R.; Bourguet, W.; Gronemeyer, H. Retinoid receptors and therapeutic applications of RAR/RXR modulators. Curr. Top Med. Chem. 2012, 12, 505–527.
92. Kroker, A.J.; Bruning, J.B. Review of the structural and dynamic mechanisms of PPAR-gamma partial agonism. PPAR Res. 2015, 2015, 816856.
93. Aydemir, G.; Kasiri, Y.; Bartok, E.M.; Birta, E.; Fröhlich, K.; Böhm, V.; Mihaly, J.; Rühl, R. Lycopene supplementation restores vitamin A deficiency in mice and possesses thereby partial pro-vitamin A activity transmitted via RAR signaling. Mol. Nutr. Food Res. 2016 60, 2413-2420.
94. Carrier, A. Metabolic syndrome and oxidative stress: A complex relationship. AntiOxid. Redox. Signal 2017, 26, 429–431.
95. Hughes, C.E.; Nibbs, R.J.B. A guide to chemokines and their receptors. FEBS J. 2018, 285, 2944–2971.
96. Zhang, J.M.; An, J. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 2007, 45, 27–37.
97. Yoshida, Y.; Umeno, A.; Shichiri, M. Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo. J. Clin. Biochem. Nutr. 2013, 52, 9–16.
98. Schaur, R.J.; Siems, W.; Bresgen, N.; Eckl, P.M. 4-Hydroxy-nonenal-a bioactive lipid peroxidation product. Biomolecules 2015, 5, 2247–2337.
99. Uchida, K.; Kanematsu, M.; Sakai, K.; Matsuda, T.; Hattori, N.; Mizuno, Y.; Suzuki, D.; Miyata, T.; Noguchi, N.; Niki, E.; et al. Protein-bound acrolein: Potential markers for oxidative stress. Proc. Natl. Acad Sci. USA 1998, 95, 4882–4887.
100. Griffiths, H.R. Antioxidants and protein oxidation. Free Radic. Res. 2000, 33, S47–S58.
101. Fedorova, M.; Bollineni, R.C.; Hoffmann, R. Protein carbonylation as a major hallmark of oxidative damage: Update of analytical strategies. Mass Spectrom. Rev. 2014, 33, 79–97.
102. Dalle-Donne, I.; Rossi, R.; Giustarini, D.; Milzani, A.; Colombo, R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329, 23–38.
103. Matsumoto, Y.; Ogawa, Y.; Yoshida, R.; Shimamori, A.; Kasai, H.; Ohta, H. The stability of the oxidative stress marker, urinary 8-hydroxy-2’-deoxyguanosine (8-OHdG), when stored at room temperature. J. Occup. Health 2008, 50, 366–372.
104. Visioli, F.; Bordone, R.; Perugini, C.; Bagnati, M.; Cau, C.; Bellomo, G. The kinetics of copper-induced LDL oxidation depend upon its lipid composition and antioxidant content. BioChem. Biophys. Res. Commun. 2000, 268, 818–822.
105. Ghaffari, M.A.; Ghiasvand, T. Kinetic study of low density lipoprotein oxidation by copper. Indian J. Clin. Biochem. 2010, 25, 29–36.
106. Moniruzzaman, M.; Khalil, M.I.; Sulaiman, S.A.; Gan, S.H. Advances in the analytical methods for determining the antioxidant properties of honey: A review. Afr. J. Tradit. Complement. Altern. Med. 2012, 9, 36–42.
107. Younus, H. Therapeutic potentials of superoxide dismutase. Int. J. Health Sci. 2018, 12, 88–93.
108. Marrocco, I.; Altieri, F.; Peluso, I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid. Med. Cell Longev. 2017, 2017, 6501046.
109. Lubos, E.; Loscalzo, J.; Handy, D.E. Glutathione peroxidase-1 in health and disease: From molecular mechanisms to therapeutic opportunities. AntiOxid. Redox Signal 2011, 15, 1957–1997.
110. Sepasi Tehrani, H.; Moosavi-Movahedi, A.A. Catalase and its mysteries. Prog. Biophys. Mol. Biol. 2018, 140, 5–12.
111. Maritim, A.C.; Sanders, R.A.; Watkins, 3rd, J.B. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003, 17, 24–38.
112. Bohm, B.; Heinzelmann, S.; Motz, M.; Bauer, G. Extracellular localization of catalase is associated with the transformed state of malignant cells. Biol. Chem. 2015, 396, 1339–1356.
113. de Jager, W.; Bourcier, K.; Rijkers, G.T.; Prakken, B.J.; Seyfert-Margolis, V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009, 10, 52.
114. Monastero, R.N.; Pentyala, S. Cytokines as biomarkers and their respective clinical cutoff levels. Int. J. Inflamm. 2017, 2017, 4309485.
115. Mühl, H.; Pfeilschifter, J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int. Immunopharmacol. 2003, 3, 1247–1255.
116. Di Paolo, N.C.; Shayakhmetov, D.M. Interleukin 1alpha and the inflammatory process. Nat. Immunol. 2016, 17, 906–913.
117. Kenis, G.; Teunissen, C.; De Jongh, R.; Bosmans, E.; Steinbusch, H.; Maes, M. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 2002, 19, 228–235.
118. Hunter, C.A.; Jones, S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 2015, 16, 448–457.
119. Berry, L.J.; Sheil, B.; Garratt, L.; Sly, P.D.; AREST, C.F. Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage. J. Cyst. Fibr. 2010, 9, 346–350.
120. Turner, M.D.; Nedjai, B.; Hurst, T.; Pennington, D.J. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta 2014, 1843, 2563–2582.
121. Doumatey, A.P.; Zhou, J.; Adeyemo, A.; Rotimi, C. High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum. Clin. Biochem. 2014, 47, 315–318.
122. Sproston, N.R.; Ashworth, J.J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 2018, 9, 754.
123. Sack, G.H., Jr. Serum amyloid A—A review. Mol. Med. 2018, 24, 46.
124. Dinarello, C.A. Proinflammatory cytokines. Chest 2000, 118, 503–508.
125. Alfaro, C.; Sanmamed, M.F.; Rodríguez-Ruiz, M.E.; Teijeira, Á.; Oñate, C.; González, Á.; Ponz, M.; Schalper, K.A.; Pérez-Gracia, J.L.; Melero, I. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat. Rev. 2017, 60, 24–31.
126. Tanaka, T.; Narazaki, M.; Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 2014, 6, a016295.
127. Polidori, M.C.; Pratico, D.; Parente, B.; Mariani, E.; Cecchetti, R.; Yao, Y.; Sies, H.; Cao, P.; Mecocci, P.; Stahl, W. Elevated lipid peroxidation biomarkers and low antioxidant status in atherosclerotic patients with increased carotid or iliofemoral intima media thickness. J. Invest. Med. 2007, 55, 163–167.
128. Martin-Gallan, P.; Carrascosa, A.; Gussinye, M.; Domínguez, C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic. Biol. Med. 2003, 34, 1563–1574.
129. Facchini, F.S.; Humphreys, M.H.; DoNascimento, C.A.; Abbasi, F.; Reaven, G.M. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am. J. Clin. Nutr. 2000, 72, 776–779.
130. Kisakol, G.; Guney, E.; Bayraktar, F.; Yilmaz, C.; Kabalak, T.; Ozmen, D. Effect of surgical weight loss on free radical and antioxidant balance: A preliminary report. Obes. Surg. 2002, 12, 795–800.
131. Senthil, S.; Veerappan, R.M.; Ramakrishna Rao, M.; Pugalendi, K.V. Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin. Chim Acta 2004, 348, 131– 137.
132. Polidori, M.C.; Praticó, D.; Savino, K.; Rokach, J.; Stahl, W.; Mecocci, P. Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. J. Card. Fail. 2004, 10, 334–338.
133. Serdar, Z.; Serdar, A.; Altin, A.; Eryilmaz, U.; Albayrak, S. The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes. Acta Cardiol. 2007, 62, 373–380.
134. Chang, C.Y.; Chen, J.Y.; Ke, D.; Hu, M.L. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: Correlation to inflammation markers and neurological deficits. Nutrition 2005, 21, 987–993.
135. Kataria, Y.; Deaton, R.J.; Enk, E.; Jin, M.; Petrauskaite, M.; Dong, L.; Goldenberg, J.R.; Cotler, S.J.; Jensen, D.M.; van Breemen, R.B.; et al. Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer. BMC Gastroenterol. 2016, 16, 30.
136. Epplein, M.; Franke, A.A.; Cooney, R.V.; Morris, J.S.; Wilkens, L.R.; Goodman, M.T.; Murphy, S.P.; Henderson, B.E.; Kolonel, L.N.; Le Marchand. L. Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: The multiethnic cohort study. Cancer Epidemiol. Prev. Biomark. 2009, 18, 1962–1970.
137. Caliskan-Can, E.; Firat, H.; Ardic, S.; Simşek, B.; Torun, M.; Yardim-Akaydin, S. Increased levels of 8-hydroxydeoxyguanosine and its relationship with lipid peroxidation and antioxidant vitamins in lung cancer. Clin. Chem. Lab. Med. 2008, 46, 107–112.
138. Tsao, S.M.; Yin, M.C.; Liu, W.H. Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Nutr. Cancer 2007, 59, 8–13.
139. Almushatat, A.S.; Talwar, D.; McArdle, P.A.; Williamson, C.; Sattar, N.; O'Reilly, D.S.; Underwood, M.A.; McMillan, D.C. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int. J. Cancer 2006, 118, 1051–1053.
140. Roehrs, M.; Valentini, J.; Paniz, C.; Moro, A.; Charão, M.; Bulcão, R.; Freitas, F.; Brucker, N.; Duarte, M.; Leal, M.; et al. The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients. BMC Nephrol. 2011, 12, 59.
141. Charao, M.F.; Moro, A.M.; Valentini, J.; Brucker, N.; Bubols, G.B.; Bulcão, R.P.; Baierle, M.; Freitas, F.A.; Nascimento, S.N.; Barth, A.; et al. Exogenous and endogenous antioxidants attenuate the lipid peroxidation in workers occupationally exposed to paints. Drug Chem. Toxicol. 2014, 37, 69–75.
142. Ren, H.; Ghebremeskel, K.; Okpala, I.; Lee, A.; Ibegbulam, O.; Crawford, M. Patients with sickle cell disease have reduced blood antioxidant protection. Int. J. Vitam. Nutr. Res. 2008, 78, 139–147.
143. Hebbel, R.P.; Eaton, J.W.; Balasingam, M.; Steinberg, M.H. Spontaneous oxygen radical generation by sickle erythrocytes. J. Clin. Invest. 1982, 70, 1253–1259.
144. Maor, I.; Rainis, T.; Lanir, A.; Lavy, A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn’s disease: Distinction between active and non-active disease. Dig. Dis. Sci. 2008, 53, 2208–2214.
145. Cemek, M.; Dede, S.; Bayiroglu, F.; Caksen, H.; Cemek, F.; Yuca, K. Oxidant and antioxidant levels in children with acute otitis media and tonsillitis: A comparative study. Int. J. Pediatr. Otorhinolaryngol. 2005, 69, 823–827.
146. Bouayed, J.; Bohn, T. Exogenous antioxidants—Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell Longev. 2010, 3, 228–237.
147. Haldar, S.; Rowland, I.R.; Barnett, Y.A.; Bradbury, I.; Robson, P.J.; Powell, J.; Fletcher, J. Influence of habitual diet on antioxidant status: A study in a population of vegetarians and omnivores. Eur. J. Clin. Nutr. 2007, 61, 1011–1022.
148. Kim, Y.; Kim, Y.J.; Lim, Y.; Oh, B.; Kim, J.Y.; Bouwman, J.; Kwon, O. Combination of diet quality score, plasma carotenoids, and lipid peroxidation to monitor oxidative stress. Oxid. Med. Cell Longev. 2018, 2018, 8601028.
149. Orhon, F.S.; Ulukol, B.; Kahya, D.; Cengiz, B.; Başkan, S.; Tezcan, S. The influence of maternal smoking on maternal and newborn oxidant and antioxidant status. Eur. J. Pediatr. 2009, 168, 975–981.
150. Suwannalert, P.; Boonsiri, P.; Khampitak, T.; Khampitak, K.; Sriboonlue, P.; Yongvanit, P. The levels of lycopene, alpha-tocopherol and a marker of oxidative stress in healthy northeast Thai elderly. Asia Pac J. Clin. Nutr. 2007, 16 Suppl 1, 27-30.
151. Zhou, Y.E.; Buchowski, M.S.; Liu, J.; Schlundt, D.G.; Ukoli, F.; Blot, W.J.; Hargreaves, M.K. Plasma lycopene is associated with pizza and pasta consumption in middle-aged and older african american and white adults in the southeastern USA in a cross-sectional study. PLoS ONE 2016, 11, e0161918.
152. Rink, S.M.; Mendola, P.; Mumford, S.L.; Poudrier, J.K.; Browne, R.W.; Wactawski-Wende. J.; Perkins, N.J.; Schisterman, E.F. Self-report of fruit and vegetable intake that meets the 5 a day recommendation is associated with reduced levels of oxidative stress biomarkers and increased levels of antioxidant defense in premenopausal women. J. Acad. Nutr. Diet. 2013, 113, 776–785.
153. Weber, D.; Stuetz, W.; Toussaint, O.; Debacq-Chainiaux, F.; Dollé, M.E.T.; Jansen, E.; Gonos, E.S.; Franceschi, C.; Sikora, E.; Hervonen, A.; et al. Associations between specific redox biomarkers and age in a large European cohort: The MARK-AGE project. Oxid. Med. Cell Longev. 2017, 2017, 1401452.
154. Parfitt, V.J.; Rubba, P.; Bolton, C.; Marotta, G.; Hartog, M.; Mancini, M. A comparison of antioxidant status and free radical peroxidation of plasma lipoproteins in healthy young persons from Naples and Bristol. Eur. Heart J. 1994, 15, 871–876.
155. Pincemail, J.; Vanbelle, S.; Gaspard, U.; Collette, G.; Haleng, J.; Cheramy-Bien, J.P.; Charlier, C.; Chapelle, J.P.; Giet, D.; Albert, A.; et al. Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of liege, belgium. Hum. Reprod. 2007, 22, 2335–2343.
156. Mazereeuw, G.; Herrmann, N.; Andreazza, A.C.; Khan, M.M.; Lanctôt, K.L. A meta-analysis of lipid peroxidation markers in major depression. Neuropsychiatr. Dis. Treat. 2015, 11, 2479–2491.
157. Tsuboi, H.; Shimoi, K.; Kinae, N.; Oguni, I.; Hori, R.; Kobayashi, F. Depressive symptoms are independently correlated with lipid peroxidation in a female population: Comparison with vitamins and carotenoids. J. Psychosom. Res. 2004, 56, 53–58.
158. Berr, C.; Richard, M.J.; Roussel, A.M.; Bonithon-Kopp, C. Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du vieillissement arteriel. Free Radic. Biol. Med. 1998, 24, 1202–1208.
159. Rehman, K.; Akash, M.S.H. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: How are they interlinked? J. Cell Biochem. 2017, 118, 3577–3585.
160. Gill, J.G.; Piskounova, E.; Morrison, S.J. Cancer, oxidative stress, and metastasis. Cold Spring Harb. Symp. Quant. Biol. 2016, 81, 163–175.
161. Hamer, M.; Chida, Y. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: Systematic review and meta-analysis. J. Hypertens. 2007, 25, 2361–2369.
162. Shardell, M.D.; Alley, D.E.; Hicks, G.E.; Etl-Kamary, S.S.; Miller, R.R.; Semba, R.D.; Ferrucci, L. Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: The third national health and nutrition examination survey. Nutr. Res. 2011, 31, 178–189.
163. Zhao, L.G.; Zhang, Q.L.; Zheng, J.L.; Li, H.L.; Zhang, W.; Tang, W.G.; Xiang, Y.B. Dietary, circulating beta-carotene and risk of all-cause mortality: A meta-analysis from prospective studies. Sci. Rep. 2016, 6, 26983.
164. Huang, J.; Weinstein, S.J.; Yu, K.; Männistö, S.; Albanes, D. Serum beta carotene and overall and cause-specific mortality. Circ. Res. 2018, 123, 1339–1349.
165. Besler, H.T.; Comoglu, S.; Okcu, Z. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr. Neurosci. 2002, 5, 215–220.
166. Codoner-Franch, P.; Pons-Morales, S.; Boix-Garcia, L.; Valls-Bellés, V. Oxidant/antioxidant status in obese children compared to pediatric patients with type 1 diabetes mellitus. Pediatr. Diabetes 2010, 11, 251–257.
167. Polidori, M.C.; Savino, K.; Alunni, G.; Freddio, M.; Senin, U.; Freddio, M.; Senin, U.; Sies, H.; Stahl, W.; Mecocci, P. Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: Relationship to disease severity. Free Radic. Biol. Med. 2002, 32, 148–152.
168. Naziroglu, M.; Kokcam, I.; Simsek, H.; Karakılçık, A.; Naziroǧlu, M. Lipid peroxidation and antioxidants in plasma and red blood cells from patients with pemphigus vulgaris. J. Basic Clin. Physiol Pharmacol. 2003, 14, 31–42.
169. Bohn, T. Bioavailabilty of non-provitamin A carotenoids. Curr. Nutr. Food Sci. 2008, 4, 240–258.
170. Bohn, T. Provitamin A carotenoids—Occurrence, intake, and bioavailability. In Vitamin A and Carotenoids: Chemistry, Analysis, Function and Effects (Food and Nutritional Components in Focus); Preedy, V., Ed.; RSC Publishing: London, UK, 2012.
171. Winklhofer-Roob, B.M.; Puhl, H.; Khoschsorur, G.; Hof, M.A.V.; Esterbauer, H.; Shmerling, D.H. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. Free Radic. Biol. Med. 1995, 18, 849–859.
172. Renner, S.; Rath, R.; Rust, P.; Lehr, S.; Frischer, T.; Elmadfa, I.; Eichler, I. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 2001, 56, 48–52.
173. Levy, Y.; Zaltsberg, H.; Ben-Amotz, A.; Levy, Y.; Aviram, M. Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Ann. Nutr. Metab. 2000, 44, 54–60.
174. Allard, J.P.; Royall, D.; Kurian, R.; Muggli, R.; Jeejeebhoy, K.N. Effects of beta-carotene supplementation on lipid peroxidation in humans. Am. J. Clin. Nutr. 1994, 59, 884–890.
175. Kim, J.H.; Chang, M.J.; Choi, H.D.; Youn, Y.K.; Kim, J.T.; Oh, J.M. Protective effects of Haematococcus astaxanthin on oxidative stress in healthy smokers. J. Med. Food 2011, 14, 1469–1475.
176. Naguib, Y.M. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48, 1150–1154.
177. Hininger, I.; Chopra, M.; Thurnham, D.I.; Laporte, F.; Richard, M.J.; Favier, A.; Roussel, A.M. Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers. Eur. J. Clin. Nutr. 1997, 51, 601–606.
178. Ademowo, O.S.; Dias, H.K.I., Milic, I.; Devitt, A.; Moran, R.; Mulcahy, R.; Howard, A.; Nolan, J.; Griffiths, H.; Dias, I. Phospholipid oxidation and carotenoid supplementation in Alzheimer’s disease patients. Free Radic. Biol. Med. 2017, 108, 77–85.
179. Souci, S.W.; Fachmann, W.; Kraut, H. Food Compoisition and Nutrition Tables. CRC press: Boca Raton, FL, USA, 2000; Volume: 6.
180. Catanzaro, R.; Zerbinati, N.; Solimene, U.; Marcellino, M.; Mohania, D.; Italia, A.; Ayala, A.; Marotta, F. Beneficial effect of refined red palm oil on lipid peroxidation and monocyte tissue factor in HCV-related liver disease: A randomized controlled study. Hepatobiliary Pancreat Dis. Int. 2016, 15, 165–172.
181. Sarkar, P.D.; Gupt, T.; Sahu, A. Comparative analysis of lycopene in oxidative stress. J. Assoc. Physicians India 2012, 60, 17–19.
182. Bose, K.S.; Agrawal, B.K. Effect of lycopene from tomatoes (cooked) on plasma antioxidant enzymes, lipid peroxidation rate and lipid profile in grade-I hypertension. Ann. Nutr. Metab. 2007 51, 477-481.
183. Giovannucci, E. Commentary: Serum lycopene and prostate cancer progression: A re-consideration of findings from the prostate cancer prevention trial. Cancer Causes Control 2011, 22, 1055–1059.
184. Giovannucci, E.; Liu, Y.; Platz, E.A.; Stampfer, M.J.; Willett, W.C. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int. J. Cancer 2007 121, 1571-1578.
185. 185. van Breemen, R.B.; Sharifi, R.; Viana, M.; Pajkovic, N.; Zhu, D.; Yuan, L.; Yang, Y.; Bowen, P.E.; Stacewicz-Sapuntzakis, M. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized, controlled trial. Cancer Prev. Res. 2011, 4, 711–718.
186. Elmadfa, I.; Rust, P.; Majchrzak, D.; Wagner, K.H.; Genser, D.; Lettner, R.; Pinter, M. Effects of beta-carotene supplementation on free radical mechanism in healthy adult subjects. Int. J. Vitam. Nutr. Res. 2004, 74, 147– 152.
187. Mobarhan, S.; Bowen, P.; Andersen, B.; Evans, M.; Stacewicz-Sapuntzakis, M.; Sugerman, S.; Simms, P.; Lucchesi, D.; Friedman, H. Effects of beta-carotene repletion on beta-carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men. Nutr. Cancer 1990, 14, 195–206.
188. Kawashima, A.; Madarame, T.; Koike, H.; Komatsu, Y.; A Wise, J. Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjects. Asia Pac. J. Clin. Nutr. 2007, 16, 411–421.
189. Hininger, I.A.; Meyer-Wenger, A.; Moser, U.; Wright, A.; Southon, S.; Thurnham, D.; Chopra, M.; Berg, H.V.D.; Olmedilla, B.E; Favier, A.; et al. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J. Am. Coll. Nutr. 2001, 20, 232–238.
190. Wang, M.X.; Jiao, J.H.; Li, Z.Y.; Liu, R.-R.; Shi, Q.; Ma, L. Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers. Atherosclerosis 2013, 227, 380–385.
191. Perrone, S.; Tei, M.; Longini, M.; Santacroce, A.; Turrisi, G.; Proietti, F.; Felici, C.; Picardi, A.; Bazzini, F.; Vasarri, P.; et al. Lipid and protein oxidation in newborn infants after lutein administration. Oxid. Med. Cell Longev. 2014, 2014, 781454.
192. Perrone, S.; Longini, M.; Marzocchi, B.; Picardi, A.; Bellieni, C.V.; Proietti, F.; Rodriguez, A.; Turrisi, G.; Buonocore, G. Effects of lutein on oxidative stress in the term newborn: A pilot study. Neonatology 2010, 97, 36–40.
193. Rubin, L.P.; Chan, G.M.; Barrett-Reis, B.M.; Fulton, A.B.; Hansen, R.M.; Ashmeade, T.L.; Oliver, J.S.; Mackey, A.D.; A Dimmit, R.; E Hartmann, E.; et al. Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants. J. Perinatol. 2011, 32, 418–424.
194. Miyazawa, T.; Nakagawa, K.; Takekoshi, H.; Higuchi, O.; Kato, S.; Kondo, M.; Kimura, F.; Miyazawa, T. Ingestion of chlorella reduced the oxidation of erythrocyte membrane lipids in senior Japanese subjects. J. Oleo. Sci. 2013, 62, 873–881.
195. Nakagawa, K.; Kiko, T.; Miyazawa, T.; Kimura, F.; Satoh, A.; Miyazawa, T. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br. J. Nutr. 2011, 105, 1563–1571.
196. Devaraj, S.; Mathur, S.; Basu, A.; Aung, H.H.; Vasu, V.T.; Meyers, S.; Jialal, I. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J. Am. Coll. Nutr. 2008, 27, 267–273.
197. Briviba, K.; Bub, A.; Moseneder, J.; Schwerdtle, T.; Hartwig, A.; Kulling, S.E.; Watzl, B. No differences in DNA damage and antioxidant capacity between intervention groups of healthy, nonsmoking men receiving 2, 5, or 8 servings/day of vegetables and fruit. Nutr. Cancer 2008, 60, 164–170.
198. Misra, R.; Mangi, S.; Joshi, S.; Mittal, S.; Gupta, S.K.; Pandey, R.M. LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: A randomized controlled clinical trial. J. Obstet. Gynaecol. Res. 2006, 32, 299–304.
199. Engelhard, Y.N.; Gazer, B.; Paran, E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: A double-blind, placebo-controlled pilot study. Am. Heart J. 2006, 151, 100.
200. Mackinnon, E.S.; Rao, A.V.; Rao, L.G. Dietary restriction of lycopene for a period of one month resulted in significantly increased biomarkers of oxidative stress and bone resorption in postmenopausal women. J. Nutr. Health Aging 2011, 15, 133–138.
201. Pandey, K.B.; Rizvi, S.I. Anti-oxidative action of resveratrol: Implications for human health. Arab. J. Chem. 2011, 4, 293–298.
202. Jowko, E.; Dlugolecka, B.; Makaruk, B.; Cieśliński, I. The effect of green tea extract supplementation on exercise-induced oxidative stress parameters in male sprinters. Eur. J. Nutr. 2015, 54, 783–791.
203. Minzanova, T.S.; Mironov, F.V.; Arkhipova, M.D.; Khabibullina, A.V.; Mironova. L.G.; Zakirova. Y.M.; Milyukov. V.A. Biological activity and pharmacological application of pectic polysaccharides: A review. Polymers 2018, 10, 1407.
204. Haegele, A.D.; Gillette, C.; O’Neill, C.; Wolfe, P.; Heimendinger, J.; Sedlacek, S.; Thompson, H.J. Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol. Biomark. Prev. 2000, 9, 421–425.
205. Thompson, H.J.; Heimendinger, J.; Diker, A.; Meinecke, B.; Wolfe, P.; Zhu, Z.; Heimendinger, J.; Diker, A.; Sedlacek, S.; Jiang, W. Dietary botanical diversity affects the reduction of oxidative biomarkers in women due to high vegetable and fruit intake. J. Nutr. 2006, 136, 2207–2212.
206. The Alpha-tocopherol Beta-Carotene Cancer Prevention Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The alpha-tocopherol, beta carotene cancer prevention study group. N Engl. J. Med. 1994, 330, 1029–1035.
207. Druesne-Pecollo, N.; Latino-Martel, P.; Norat, T.; Barrandon, E.; Bertrais, S.; Galan, P.; Hercberg, S. Beta-carotene supplementation and cancer risk: A systematic review and metaanalysis of randomized controlled trials. Int. J. Cancer 2010, 127, 172–184.
208. Hennekens, C.H.; Buring, J.E.; Manson, J.E.; Stampfer, M.; Rosner, B.; Cook, N.R.; Belanger, C.; LaMotte, F.; Gaziano, J.M.; Ridker, P.M.; et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl. J. Med. 1996, 334, 1145–1149.
209. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002, 360, 23–33.
210. Blot, W.J.; Li, J.Y.; Taylor, P.R.; Guo, W.; Dawsey, S.M.; Li, B. The Linxian trials: Mortality rates by vitamin-mineral intervention group. Am. J. Clin. Nutr. 1995, 62, 1424S–1426S.
211. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012, 14, Cd007176.
212. Xu, X.R.; Zou, Z.Y.; Xiao, X.; Huang, Y.M.; Wang, X.; Lin, X.M. Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population. J. Atheroscler. Thromb. 2013, 20, 170–177.
213. McEneny, J.; Wade, L.; Young, I.S.; Masson, L.; Duthie, G.; McGinty, A.; McMaster, C.; Thies, F. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J. Nutr. Biochem. 2013, 24, 163–168.
214. Riso, P.; Visioli, F.; Grande, S.; Guarnieri, S.; Gardana, C.; Simonetti, P.; Porrini, M. Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J. Agric. Food Chem. 2006, 54, 2563–2566.
215. Biddle, M.J.; Lennie, T.A.; Bricker, G.V.; Kopec, R.E.; Schwartz, S.J.; Moser, D.K. Lycopene dietary intervention: A pilot study in patients with heart failure. J. Cardiovasc. Nurs. 2015, 30, 205–212.
216. Watzl, B.; Bub, A.; Blockhaus, M.; LührmannP.M.; Neuhäuser-BertholdM.; Rechkemmer, G.; Bub, A. Prolonged tomato juice consumption has no effect on cell-mediated immunity of well-nourished elderly men and women. J. Nutr. 2000, 130, 1719–1723.
217. Lee, C. Collaborative power of Nrf2 and PPARgamma activators against metabolic and drug-induced oxidative injury. Oxid. Med. Cell Longev. 2017, 2017, 1378175.
218. Zhang, X.; Zhao, W.E.; Hu, L.; Zhao, L.; Huang, J. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARgamma) in K562 cancer cells. Arch. Biochem. Biophys. 2011, 512, 96–106.